A drug to fight antibiotic resistance, a cancer-detecting test & more: 4 latest FDA approvals

Here are four drugs or medical devices that have been approved by the FDA since Sept. 28:

1. Libtayo is an injection for patients with metastatic cutaneous squamous cell carcinoma, the second most common skin cancer. It works by helping the body's immune system fight the cancer cells.

2. ClonoSEQ assay, a next generation sequencing test, detects very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma.

3. Insmed received approval for Arikayce for the treatment of a lung disease caused by a group of bacteria, Mycobacterium avium The treatment would be used as part of a combination regimen for adult patients who have limited or no alternative treatment options.

4. Nuzyra, a modernized tetracycline antibiotic, was approved for the treatment of community-acquired bacterial pneumonia and acute skin infections. It is an updated version of the antibiotic that can attack antibiotic-resistant strains.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars